Haemonetics 2nd Quarter Fiscal Year 2025 Earnings Release Available on Investor Relations Website
Haemonetics (NYSE: HAE) announced the availability of its second quarter fiscal year 2025 financial results, ended September 28, 2024, on its Investor Relations website. The company will host a conference call and webcast with investors and analysts on November 7, 2024, at 8:00 a.m. ET to discuss the results. Participants are recommended to join 10 minutes before the event starts. A replay of the conference call and webcast will be available for one year starting November 7, 2024, at 11:00 a.m. ET.
Haemonetics (NYSE: HAE) ha annunciato la disponibilità dei risultati finanziari del secondo trimestre dell'anno fiscale 2025, conclusosi il 28 settembre 2024, sul suo sito web per le relazioni con gli investitori. L'azienda ospiterà una call e webcast con investitori e analisti il 7 novembre 2024, alle 8:00 ET per discutere i risultati. Si consiglia ai partecipanti di unirsi 10 minuti prima dell'inizio dell'evento. La registrazione della call e del webcast sarà disponibile per un anno a partire dal 7 novembre 2024, alle 11:00 ET.
Haemonetics (NYSE: HAE) anunció la disponibilidad de los resultados financieros del segundo trimestre del año fiscal 2025, que finalizó el 28 de septiembre de 2024, en su sitio web de relaciones con los inversores. La compañía llevará a cabo una conferencia telefónica y webcast con inversores y analistas el 7 de noviembre de 2024, a las 8:00 a.m. ET para discutir los resultados. Se recomienda a los participantes unirse 10 minutos antes de que comience el evento. Una reproducción de la conferencia telefónica y el webcast estará disponible durante un año a partir del 7 de noviembre de 2024, a las 11:00 a.m. ET.
Haemonetics (NYSE: HAE)는 2024년 9월 28일 종료된 2025 회계연도 2분기 재무 결과의 가용성을 투자자 관계 웹사이트에 발표했습니다. 회사는 2024년 11월 7일 오전 8시(ET)에 투자자 및 분석가와 함께 결과를 논의하기 위해 전화 회의 및 웹캐스트를 개최할 예정입니다. 참가자는 이벤트 시작 10분 전에 참여하는 것이 권장됩니다. 전화 회의 및 웹캐스트의 재생은 2024년 11월 7일 오전 11시(ET)부터 1년 동안 사용할 수 있습니다.
Haemonetics (NYSE: HAE) a annoncé la disponibilité de ses résultats financiers du deuxième trimestre de l'exercice 2025, clos le 28 septembre 2024, sur son site web de relations avec les investisseurs. L'entreprise animera une conférence téléphonique et un webcast avec des investisseurs et des analystes le 7 novembre 2024, à 8h00 ET, pour discuter des résultats. Il est recommandé aux participants de se connecter 10 minutes avant le début de l'événement. Un replay de la conférence téléphonique et du webcast sera disponible pendant un an à partir du 7 novembre 2024, à 11h00 ET.
Haemonetics (NYSE: HAE) hat die Verfügbarkeit seiner finanziellen Ergebnisse für das zweite Quartal des Geschäftsjahres 2025, das am 28. September 2024 endete, auf seiner Website für Investor Relations bekannt gegeben. Das Unternehmen wird am 7. November 2024 um 8:00 Uhr ET eine Telefonkonferenz und einen Webcast mit Investoren und Analysten abhalten, um die Ergebnisse zu besprechen. Teilnehmer werden gebeten, 10 Minuten vor Beginn des Events beizutreten. Eine Wiederholung der Telefonkonferenz und des Webcasts wird ab dem 7. November 2024 um 11:00 Uhr ET für ein Jahr verfügbar sein.
- None.
- None.
Insights
The announcement of an upcoming earnings release and conference call, without the actual financial figures, does not provide actionable information for investors. This is a routine administrative announcement that precedes the actual earnings release and discussion. Investors should wait for the actual earnings call and financial results to make informed decisions about HAE stock.
Financial release accessible online
The Company will host a conference call and webcast with investors and analysts to discuss and answer questions about the results at 8:00 a.m. ET on November 7, 2024. The conference call and webcast can be accessed with the following information:
- Teleconference link: https://register.vevent.com/register/BI3c9f473811f94c489025845778f9dabc
- Once registration is completed, participants will receive a dial-in number along with a personalized PIN to access the call. While not required, it is recommended that participants join 10 minutes prior to the event start.
- A live webcast of the call can be accessed on Haemonetics' investor relations website or via the following link: https://edge.media-server.com/mmc/p/rcm5foqd
In addition, the Company has posted to its Investor Relations website the earnings release that will be referenced on its conference call and webcast, a link to which is available below.
Direct link to 2Q FY25 Earnings Release:
https://haemonetics.gcs-web.com/static-files/a28cb934-1e51-4489-9c9f-1a3f68dc7f5a
A replay of the conference call and webcast will be available for one year beginning on November 7, 2024, at 11:00 a.m. ET using the conference call webcast link provided in this press release.
ABOUT HAEMONETICS
Haemonetics (NYSE: HAE) is a global healthcare company dedicated to providing a suite of innovative medical products and solutions for customers, to help them improve patient care and reduce the cost of healthcare. Our technology addresses important medical markets: blood and plasma component collection, the surgical suite and hospital transfusion services. To learn more about Haemonetics, visit www.haemonetics.com.
Investor Contacts: | |
Olga Guyette, Vice President-Investor Relations & Treasury | David Trenk, Manager-Investor Relations |
(781) 356-9763 | (203) 733-4987 |
Media Contact: | |
Josh Gitelson, Sr. Director-Global Communications | |
(781) 356-9776 | |
View original content to download multimedia:https://www.prnewswire.com/news-releases/haemonetics-2nd-quarter-fiscal-year-2025-earnings-release-available-on-investor-relations-website-302298494.html
SOURCE Haemonetics Corporation
FAQ
When will Haemonetics (HAE) release Q2 FY2025 earnings?
How can I access Haemonetics (HAE) Q2 FY2025 earnings call?
How long will Haemonetics (HAE) Q2 FY2025 earnings call replay be available?
